Etanercept
Etanercept is a pharmaceutical drug with 258 clinical trials. Currently 12 active trials ongoing. Historical success rate of 89.3%.
Success Metrics
Based on 192 completed trials
Phase Distribution
Phase Distribution
29
Early Stage
50
Mid Stage
129
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
86.1%
192 of 223 finished
13.9%
31 ended early
12
trials recruiting
258
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis
Study of the Efficacy and Safety of Etanercept Treatment in Patients With SAPHO Syndrome
Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants
Treatment Tapering in JIA With Inactive Disease
Clinical Trials (258)
A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis
Study of the Efficacy and Safety of Etanercept Treatment in Patients With SAPHO Syndrome
Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants
Treatment Tapering in JIA With Inactive Disease
TNF-α Treatment of Blast-Induced Tinnitus
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis
Anti-inflammatory Therapy to Improve Outcomes After TPIAT
A Study of Nipocalimab With Co-administration of Etanercept or Hydroxychloroquine in Healthy Participants
TNF and Glucocorticoid Antagonist for GWI Associated Multi-symptom Disease Homeostasis Reset
Advanced Therapeutics in Rheumatoid Arthritis (RA)
Swiss Dermatology Network of Targeted Therapies (SDNTT)
A Study to Evaluate Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to DMARDs
STep-up and Step-down Therapeutic Strategies in Childhood ARthritiS
Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA Patients
CHronic Nonbacterial Osteomyelitis International Registry
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 258